Mobile

A Phase II Extension of a Randomized, Open-Label, Multiple-Rising Dose Clinical Trial to Study the Efficacy and Safety of MK-2578 for the Maintenance of Anemia Treatment in Patients with Chronic Kidne...

Mise à jour : Il y a 5 ans
Référence : EUCTR2009-016376-76

A Phase II Extension of a Randomized, Open-Label, Multiple-Rising Dose Clinical Trial to Study the Efficacy and Safety of MK-2578 for the Maintenance of Anemia Treatment in Patients with Chronic Kidney Disease who are on Hemodialysis

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the overall safety and tolerability of intravenous administration of MK-2578 in a 40-week extension study.

Critère d'inclusion

  • Anemia in patients with Chronic kidney disease (CKD)

Liens